Status:
UNKNOWN
Study on the Association of GSTP1 and Other Gene Polymorphisms With Platinum-induced Myelosuppression
Lead Sponsor:
LI YAN
Conditions:
Non-small Cell Lung Cancer
Eligibility:
All Genders
Brief Summary
This study intends to design a retrospective and prospective, cohort study to explore the association between genetic polymorphism of GSTP1 A313G rs1695 or others and adverse effects of platinum drugs...
Detailed Description
Patients with pulmonary malignant tumors receiving platinum-containing chemotherapy regimen were included in the retrospective and prospective bidirectional cohort study to collect the basic informati...
Eligibility Criteria
Inclusion
- Patients with non-small cell lung cancer with clear imaging or pathological evidence
- Using a chemotherapy regimen containing platinum
- Conducted blood routine and biochemical tests
- Signed informed consent
Exclusion
- Blood routine and other relevant tests were not performed
- Suffering from primary bone marrow system disease
- Other reasons for not meeting the experimental requirements
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
477 Patients enrolled
Trial Details
Trial ID
NCT06140082
Start Date
December 1 2023
End Date
December 30 2025
Last Update
November 18 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.